| Product Name | MF | CAS | Details |
|---|
| 2,8-Diazabicyclo[4.3.0]nonane | C7H14N2 | 151213-40-0 | Details |
| 3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzoic Acid | C12H12F2O4 | 162401-62-9 | Details |
| 5-METHYL-3,4-DIPHENYL-4,5-DIHYDROISOXAZOL-5-OL | C16H15NO2 | 181696-73-1 | Details |
| 3,3-DIPHENYL-OXIRANE-2-CARBOXYLIC ACID METHYL ESTER | C16H14O3 | 76527-25-8 | Details |
| Ambrisentan | C22H22N2O4 | 177036-94-1 | Details |
| N4-(4-fluorobenzyl)-1,2,4-benzenetriamine | C13H14FN3 | Details |
| Betrixaban | C23H22ClN5O3 | 330942-05-7 | Details |
| Valdecoxib | C16H14N2O3S | 181695-72-7 | Details |
| Cyclohexyl ether | C12H22O | Details |
| 3,4-dicyclopropylmethoxy-N-(3,5-dichloro-4-aminopyridyl)benzamide | C19H19Cl2N3O2 | Details |
| 3cyclopropylmethoxy-4-difluoromethyl -N- (3,5- dichloro-4-pyridine nitrogen yloxy) benzamide | Details |
| 4-(difluoroMethoxy)-3-hydroxybenzoic acid | C8H6F2O4 | 913985-07-6 | Details |
| Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate | C9H17NO2 | 74892-82-3 | Details |
| Parecoxib | C19H18N2O4S | 198470-84-7 | Details |
| Retigabine Dihydrochloride | C16H20Cl2FN3O2 | 150812-13-8 | Details |
| PARECOXIB SODIUM | C19H19N2NaO4S | 198470-85-8 | Details |
| Benzenepropanoic acid,a-hydroxy-b-methoxy-b-phenyl-,methyl ester | C17H18O4 | 178306-47-3 | Details |
| 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridyl)-4-(difluoromethoxy)dibenzoimide | Details |
| 2,8-Diazabicyclo[4.3.0]nonane | C7H14N2 | Details |
| 3-hydroxy -N- (3,5- dichloro-4-amino-pyridin-yl) -4- difluoromethoxy-benzamide | C13H9Cl2F2N3O3 | Details |
| 3,4-di(Cyclopropylmethoxy)-benzoic acid | C15H18O4 | Details |
| 3-(cyclopropylmethyl)-N-(3,5-dichloro-4-aminopyridyl)-4-(difluoromethoxy)benzamide | C17H15Cl2F2N3O2 | Details |
| Diphenylacetamidine | C14H14N2 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||